1. Home
  2. VATE vs OCUP Comparison

VATE vs OCUP Comparison

Compare VATE & OCUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VATE
  • OCUP
  • Stock Information
  • Founded
  • VATE 1994
  • OCUP 2018
  • Country
  • VATE United States
  • OCUP United States
  • Employees
  • VATE N/A
  • OCUP N/A
  • Industry
  • VATE Metal Fabrications
  • OCUP Biotechnology: Pharmaceutical Preparations
  • Sector
  • VATE Industrials
  • OCUP Health Care
  • Exchange
  • VATE Nasdaq
  • OCUP Nasdaq
  • Market Cap
  • VATE 49.2M
  • OCUP 53.1M
  • IPO Year
  • VATE 1996
  • OCUP N/A
  • Fundamental
  • Price
  • VATE $5.36
  • OCUP $1.22
  • Analyst Decision
  • VATE
  • OCUP Strong Buy
  • Analyst Count
  • VATE 0
  • OCUP 3
  • Target Price
  • VATE N/A
  • OCUP $18.67
  • AVG Volume (30 Days)
  • VATE 94.4K
  • OCUP 96.2K
  • Earning Date
  • VATE 11-07-2024
  • OCUP 11-11-2024
  • Dividend Yield
  • VATE N/A
  • OCUP N/A
  • EPS Growth
  • VATE N/A
  • OCUP N/A
  • EPS
  • VATE N/A
  • OCUP N/A
  • Revenue
  • VATE $1,364,600,000.00
  • OCUP $16,449,000.00
  • Revenue This Year
  • VATE N/A
  • OCUP N/A
  • Revenue Next Year
  • VATE N/A
  • OCUP $258.69
  • P/E Ratio
  • VATE N/A
  • OCUP N/A
  • Revenue Growth
  • VATE N/A
  • OCUP N/A
  • 52 Week Low
  • VATE $3.25
  • OCUP $1.15
  • 52 Week High
  • VATE $15.50
  • OCUP $3.40
  • Technical
  • Relative Strength Index (RSI)
  • VATE 72.35
  • OCUP 40.68
  • Support Level
  • VATE $3.25
  • OCUP $1.24
  • Resistance Level
  • VATE $4.16
  • OCUP $1.39
  • Average True Range (ATR)
  • VATE 0.33
  • OCUP 0.07
  • MACD
  • VATE 0.19
  • OCUP -0.00
  • Stochastic Oscillator
  • VATE 96.35
  • OCUP 4.76

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting stations across the United States.

About OCUP Ocuphire Pharma Inc.

Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting the front and back of the eye indications. The Nyxol candidate is being developed for dim light or night vision disturbances, reversal of pharmacologically induced mydriasis, and presbyopia. The second product candidate, APX3330, is being developed for diabetic retinopathy and diabetic macular edema.

Share on Social Networks: